SCHEMBL547774

SCHEMBL547774

C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(C(=O)O)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 7/20 0.84
SENP1 Q9P0U3 3/20 0.84
POLB P06746 3/20 0.84
HSD11B1 P28845 3/20 0.84
MEN1 O00255 2/20 0.84
KMT2A Q03164 2/20 0.84
PTPN2 P17706 2/20 0.84
PTPN6 P29350 2/20 0.84
GPBAR1 Q8TDU6 2/20 0.84
USP7 Q93009 2/20 0.84
RECQL P46063 2/20 0.84
AKR1B10 O60218 1/20 0.84
CTSD P07339 1/20 0.84
PTPRF P10586 1/20 0.84
CYP19A1 P11511 1/20 0.84
CETP P11597 1/20 0.84
AKR1B1 P15121 1/20 0.84
CES1 P23141 1/20 0.84
ACP1 P24666 1/20 0.84
EPHX2 P34913 1/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL547775 1.00 PTPN1 (0.84) PTPN1SENP1POLBHSD11B1MEN1
Ursolic Acid SCHEMBL14132123 0.91 PTPN1 (1.00) PTPN1SENP1POLBHSD11B1MEN1
Ursolic Acid SCHEMBL13395361 0.91 PTPN1 (1.00) PTPN1SENP1POLBHSD11B1MEN1
Ursolic Acid SCHEMBL18428537 0.91 PTPN1 (1.00) PTPN1SENP1POLBHSD11B1MEN1
Ursolic Acid SCHEMBL12300180 0.91 PTPN1 (1.00) PTPN1SENP1POLBHSD11B1MEN1
Ursolic Acid SCHEMBL23314191 0.91 PTPN1 (1.00) PTPN1SENP1POLBHSD11B1MEN1
Ursolic Acid SCHEMBL16994210 0.91 PTPN1 (1.00) PTPN1SENP1POLBHSD11B1MEN1
Ursolic Acid SCHEMBL19714770 0.91 PTPN1 (1.00) PTPN1SENP1POLBHSD11B1MEN1
Ursolic Acid SCHEMBL21819718 0.91 PTPN1 (1.00) PTPN1SENP1POLBHSD11B1MEN1
Ursolic Acid SCHEMBL5713287 0.91 PTPN1 (1.00) PTPN1SENP1POLBHSD11B1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 180 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4529452-B1 DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES GIULIANI SPA (IT) 2025-12-24 EP claimed
US-20250170038-A1 DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES GIULIANI S.P.A. (IT) 2025-05-29 US claimed
EP-4529452-A1 DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES Giuliani S.p.A. (IT) 2025-04-02 EP claimed
US-20240245744-A1 INTRANASAL ADMINSTRATION OF CANNABIGEROL, CBDa, CBGa, & UNCARIA TOMENTOSA HYDROALCOHOLIC EXTRACT COMPOUNDS EMULSIFIED IN SALINE HOMOGENOUS SOLUTION FOR INTRANASAL ADMINISTRATION CLARK ARTIS ASAHEL (US) 2024-07-25 US claimed
WO-2023228079-A1 DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES GIULIANI S.P.A. (IT) 2023-11-30 WO claimed
WO-2022124583-A1 COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES, COMPRISING QUINOVIC ACID 경상국립대학교 산학협력단 2022-06-16 WO claimed
CN-107115568-A Self assembly lysozyme multilayer membrane preparation method with antibiotic property and biocompatibility 温州生物材料与工程研究所 2017-09-01 CN claimed
CN-106798947-A A kind of self-assembled protein multilayer membrane preparation method 温州生物材料与工程研究所 2017-06-06 CN claimed
US-20100227827-A1 METHOD OF INCREASING TRYPTOPHAN AND NICOTINAMIDE LEVELS IN VIVO GENETIC HEALTH ENTERPRISES (PTY) LTD. (ZA) 2010-09-09 US claimed
US-20080206162-A1 Composition and Methods for Treating Alzheimer's Disease and Other Amyloidoses UNIVERSITY OF WASHINGTON 2008-08-28 US claimed
WO-2008008837-A2 A METHOD OF INCREASING TRYPTOPHAN AND NICOTINAMIDE LEVELS IN VIVO LYNPETE TRADING 6 (PTY) LTD. TRADING AS GENETIC HEALTH ENTERPRISES (ZA) 2008-01-17 WO claimed
EP-1019044-B1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIV WASHINGTON (US) 2007-04-11 EP claimed
US-20040086585-A1 Composition and methods for treating Alzheimer's disease and other amyloidoses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-05-06 US claimed
US-20040076698-A1 Composition and methods for treating Alzheimer's disease and other amyloidoses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-04-22 US claimed
EP-1019044-A4 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIV WASHINGTON (US) 2004-01-07 EP claimed
US-20010055630-A1 Compostion and methods for treating alzheimer's disease and other amyloidoses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2001-12-27 US claimed
EP-1019044-A1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES University of Washington (US) 2000-07-19 EP claimed
WO-1998051302-A1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIVERSITY OF WASHINGTON (US) 1998-11-19 WO claimed
US-4606911-A PENTACYCLIC ACID TRITERPENES ROHTO PHARMACEUTICAL CO. LTD. (JP) 1986-08-19 US claimed
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2026-04-30 US disclosed
EP-4529452-B1 DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES GIULIANI SPA (IT) 2025-12-24 EP disclosed
EP-4593631-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME Mars, Incorporated (US) 2025-08-06 EP disclosed
US-20250170038-A1 DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES GIULIANI S.P.A. (IT) 2025-05-29 US disclosed
EP-4529452-A1 DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES Giuliani S.p.A. (IT) 2025-04-02 EP disclosed
CN-119654128-A Dosage forms for topical administration of pentacyclic triterpenes 朱利亚尼股份公司 2025-03-18 CN disclosed
WO-2024073025-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2024-04-04 WO disclosed
EP-4344552-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2024-04-03 EP disclosed
US-20240100113-A1 TERPENE-CONTAINING COMPOSITIONS QSI HOLDING COMPANY INC (US) 2024-03-28 US disclosed
WO-2023228079-A1 DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES GIULIANI S.P.A. (IT) 2023-11-30 WO disclosed
WO-2022124583-A1 COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES, COMPRISING QUINOVIC ACID 경상국립대학교 산학협력단 2022-06-16 WO disclosed
WO-2022124583-A1 COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES, COMPRISING QUINOVIC ACID 경상국립대학교 산학협력단 2022-06-16 WO disclosed
US-20210346453-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF COVID-19 COGNITIVE CLARITY INC. (US) 2021-11-11 US disclosed
US-20210346385-A1 TASTE-MASKED DOSAGE FORMS DEEP OCEAN CAPITAL MANAGEMENT LP 2021-11-11 US disclosed
WO-2020061584-A1 TASTE-MASKED DOSAGE FORMS MSB HOLDINGS, INC. (US) 2020-03-26 WO disclosed
CN-110179009-A A kind of natural plant feed raw material compound and preparation method thereof for improving laying hen premunition 河南牧翔动物药业有限公司 2019-08-30 CN disclosed
CN-110075313-A A kind of lipoid composition and preparation method thereof carrying protein/polypeptide 南京中医药大学 2019-08-02 CN disclosed
CN-108484401-A A kind of technique of the chlorogenic acid extracting from new fresh honeysuckle 肖锦 2018-09-04 CN disclosed
CN-108373413-A A method of the chlorogenic acid extracting from Cortex Eucommiae 肖锦 2018-08-07 CN disclosed
US-20180207113-A1 VIVO INTRACELLULAR REPROGRAMMING COMPOSITION AND METHOD OF MAKING AND USING SAME GIAMPAPA VINCENT C (US) 2018-07-26 US disclosed
CN-107824057-A A kind of dissaving polymer modifying polymer film and preparation method and application 天津工业大学 2018-03-23 CN disclosed
CN-107670513-A A kind of plant polyphenol modifying polymer film and preparation method and application 天津工业大学 2018-02-09 CN disclosed
CN-107115568-A Self assembly lysozyme multilayer membrane preparation method with antibiotic property and biocompatibility 温州生物材料与工程研究所 2017-09-01 CN disclosed
CN-106798947-A A kind of self-assembled protein multilayer membrane preparation method 温州生物材料与工程研究所 2017-06-06 CN disclosed
CN-105622420-A Preparation method of Eucommia ulmoides chlorogenic acid XIANGYANG LIGAOLE BIOCHEMICAL TECH CO LTD 2016-06-01 CN disclosed
CN-104017103-B A kind of nauclea officinalis water-soluble polysaccharide and preparation method thereof and application HAINAN PHARMACEUTICAL FACTORY CO., LTD. (CN) 2016-02-10 CN disclosed
EP-1786446-B1 Hydroalcoholic extract of Uncaria tomentosa for the treatment of herpes virus infection HERBARIUM LABORATÓRIO BOTÁNICO LTDA (BR) 2015-09-30 EP disclosed
CN-104688720-A Application of chlorogenic acid in preparation of medicine for treating melanoma and medicine for treating melanoma SICHUAN JIUZHANG BIOTECHNOLOGY CO LTD 2015-06-10 CN disclosed
CN-104490980-A Method for low temperature extraction of eucommia chlorogenic acid by cell wall breaking HUBEI LAOLONGDONG DUZHONG DEV CO LTD 2015-04-08 CN disclosed
US-8945518-B2 Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions UNIGEN, INC. (US) 2015-02-03 US disclosed
US-8906423-B2 Topical phytotherapeutic compound for the treatment of herpes based on Uncaria tomentosa and extraction process for obtaining a vegetal extract from Uncaria tomentosa HERBARIUM LABORATORIO BOTANICO LTDA. (BR) 2014-12-09 US disclosed
WO-2014153356-A1 AN IN VIVO INTRACELLULAR REPROGRAMMING COMPOSITION AND METHOD OF MAKING AND USING SAME LIFE SCIENCE INSTITUTE, LLC (US) 2014-09-25 WO disclosed
CN-104017103-A Water-soluble nauclea officinalis polysaccharide as well as preparation method and application thereof Hainan pharmaceutical factory co ltd 2014-09-03 CN disclosed
US-8741359-B2 Method for testing a substance which is potentially active in the field of lipolysis and its mainly cosmetic use BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2014-06-03 US disclosed
CN-102579419-B Novel anticancer application of chlorogenic acid JIUZHANG BIOCHEMICAL ENGINEERING SCIENCE AND TECHNOLOGY DEV CO LTD 2014-02-19 CN disclosed
CN-102267906-B Extraction method for chlorogenic acid HUNAN CHANGSHA YUANHANG BIOLOGY PRODUCT CO LTD 2014-01-15 CN disclosed
US-8394424-B2 Topical phytotherapeutic compound for the treatment of herpes based on Uncaria tomentosa and extraction process for obtaining a vegetal extract from Uncaria tomentosa HERBARIUM LABORATORIO BOTANICO LTDA. (BR) 2013-03-12 US disclosed
US-20120269910-A1 Method for Testing a Substance Which is Potentially Active in the Field of Lipolysis and its Mainly Cosmetic Use BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) 2012-10-25 US disclosed
US-8231913-B2 Angina pectoris and ischemic heart disease and synergistic phytoceutical composition for same OLALDE RANGEL JOSE ANGEL (VE) 2012-07-31 US disclosed
CN-102579419-A Novel anticancer application of chlorogenic acid JIUZHANG BIOCHEMICAL ENGINEERING SCIENCE AND TECHNOLOGY DEV CO LTD 2012-07-18 CN disclosed
CN-102488682-A New application of chlorogenic acid in cancer resisting SICHUAN JIUZHANG BIOCHEMICAL ENGINEERING SCIENCE AND TECHNOLOGY DEV CO LTD 2012-06-13 CN disclosed
US-20120141611-A1 METHODS AND COMPOSITIONS USING ERGOTHIONEINE TO TREAT A VARIETY OF HEALTH RELATED FACTORS OXIS INTERNATIONAL INC. 2012-06-07 US disclosed
CN-101328123-B 5-oxo-substituted benzene acryloyl quinate methyl ester compound and use thereof UNIV ZHEJIANG 2012-05-23 CN disclosed
CN-101457192-B Papaya sake and production method thereof HENAN HUAIYUAN WINE CO LTD 2012-05-23 CN disclosed
US-8110230-B2 Synergistic phytoceutical compositions OLALDE RANGEL JOSE ANGEL (VE) 2012-02-07 US disclosed
CN-102267906-A Extraction method for chlorogenic acid 2011-12-07 CN disclosed
US-8062680-B2 Synergistic phytoceutical compositions OLALDE RANGEL JOSE ANGEL (VE) 2011-11-22 US disclosed
CN-101618016-B Method for preparing W/O/W type compound emulsion embedding chlorogenic acid, product and application of W/O/W type compound emulsion HUABAO FOOD FLAVORS & FRAGRANCES SHANGHAI CO LTD 2011-09-28 CN disclosed
CN-101695486-B Use of chlorogenic acid in preparing medicament for treating marrow fibrillation JIUZHANG BIOCHEMICAL ENGINEERING SCIENCE AND TECHNOLOGY DEV CO LTD 2011-09-07 CN disclosed
CN-101703497-B Application of Chlorogenic acid in preparing drug having protection and restoration functions on spleen hematopoietic stem cell injuries JIUZHANG BIOCHEMICAL ENGINEERING SCIENCE AND TECHNOLOGY DEV CO LTD 2011-08-24 CN disclosed
CN-101695485-B Use of chlorogenic acid in preparing medicament for treating thrombocytopenia and anemia JIUZHANG BIOCHEMICAL ENGINEERING SCIENCE AND TECHNOLOGY DEV CO LTD 2011-07-13 CN disclosed
WO-2011056244-A1 ANGINA PECTORIS AND ISCHEMIC HEART DISEASE AND SYNERGISTIC PHYTOCEUTICAL COMPOSITION FOR SAME OLALDE RANGEL JOSE ANGEL (US) 2011-05-12 WO disclosed
US-20110052718-A1 Synergistic Phytoceutical Compositions RANGEL JOSE ANGEL OLALDE 2011-03-03 US disclosed
US-20110020226-A1 PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS NORDIC VACCINE TECHNOLOGY A/S 2011-01-27 US disclosed
CN-101926811-A Triterpenoid saponin total extract of Chinese starjasmine stem and preparation method and application thereof NO 98 HOSPITAL OF THE PLA 2010-12-29 CN disclosed
US-20100233299-A1 TOPICAL PHYTOTHERAPEUTIC COMPOUND FOR THE TREATMENT OF HERPES BASED ON UNCARIA TOMENTOSA AND EXTRACTION PROCESS FOR OBTAINING A VEGETAL EXTRACT FROM UNCARIA TOMENTOSA TRENTINI ANNY MARGALY MACIEL 2010-09-16 US disclosed
US-20100227827-A1 METHOD OF INCREASING TRYPTOPHAN AND NICOTINAMIDE LEVELS IN VIVO GENETIC HEALTH ENTERPRISES (PTY) LTD. (ZA) 2010-09-09 US disclosed
CN-101212963-B Application of chlorogenic acid in preparing medicine for increasing bone marrow cell efficacy SICHUAN NYNESTEP BIOTECH CO LTD 2010-08-25 CN disclosed
CN-101774920-A Preparation method of 3,5-cynarin methyl ester and medicament composition thereof 302 MILITARY HOSPITAL CHINA 2010-07-14 CN disclosed
US-7754250-B2 Composition and methods for treating Alzheimer's disease and other amyloidoses PROTEOTECH, INC. (US) 2010-07-13 US disclosed
US-20100143398-A1 Synergistic Phytoceutical Compositions OLALDE RANGEL JOSE ANGEL 2010-06-10 US disclosed
US-20100143397-A1 Synergistic Phytoceutical Compositions OLALDE RANGEL JOSE ANGEL 2010-06-10 US disclosed
US-20100119629-A1 ANGINA PECTORIS AND ISCHEMIC HEART DISEASE AND SYNERGISTIC PHYTOCEUTICAL COMPOSITION FOR SAME OLALDE RANGEL JOSE ANGEL 2010-05-13 US disclosed
CN-101703497-A Application of Chlorogenic acid in preparing drug having protection and restoration functions on spleen hematopoietic stem cell injuries JIUZHANG BIOCHEMICAL ENGINEERI 2010-05-12 CN disclosed
US-7713942-B2 Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides NORDIC VACCINE TECHNOLOGY A/S (DK) 2010-05-11 US disclosed
CN-101695484-A Use of chlorogenic acid in preparing medicament for treating marrow infection JIUZHANG BIOCHEMICAL ENGINEERI 2010-04-21 CN disclosed
CN-101695486-A Use of chlorogenic acid in preparing medicament for treating marrow fibrillation JIUZHANG BIOCHEMICAL ENGINEERI 2010-04-21 CN disclosed
CN-101695485-A Use of chlorogenic acid in preparing medicament for treating thrombocytopenia and anemia JIUZHANG BIOCHEMICAL ENGINEERI 2010-04-21 CN disclosed
US-7682616-B2 Synergistic phytoceutical compositions OLALDE RANGEL JOSE ANGEL 2010-03-23 US disclosed
US-7682617-B2 Synergistic phytoceutical compositions OLALDE RANGEL JOSE ANGEL 2010-03-23 US disclosed
CN-101618016-A Method for preparing W/O/W type compound emulsion embedding chlorogenic acid, product and application of W/O/W type compound emulsion HUABAO FOOD FLAVORS & FRAGRANC 2010-01-06 CN disclosed
US-7618639-B2 Synergistic phytoceutical compositions OLALDE RANGEL JOSE ANGEL 2009-11-17 US disclosed
US-7604823-B2 Synergistic HIV/AIDS and/or immune disease phyto-nutraceutical composition Olalde Rangel, Jose Angel (US) 2009-10-20 US disclosed
CN-100546601-C Radix Gei japonici antineoplastic extract and its production and use UNIV SOUTH CHINA TECH (CN) 2009-10-07 CN disclosed
CN-100546602-C Anti-tumor compound polygoni cuspidati,radix, Radix Actinidiae Chinensis, Radix Gei japonici preparation and its production and application UNIV SOUTH CHINA TECH (CN) 2009-10-07 CN disclosed
US-20090196941-A1 Synergistic Phytoceutical Compositions OLALDE RANGEL JOSE ANGEL 2009-08-06 US disclosed
CN-101492374-A Disubstituted-L-tartaric dimethyl ester compounds and medical use WENZHOU MEDICAL COLLEGE (CN) 2009-07-29 CN disclosed
CN-101492373-A Disubstituted fragrant acyl ethylene glycol compounds and medical use WENZHOU MEDICAL COLLEGE (CN) 2009-07-29 CN disclosed
CN-101492371-A Disubstituted benzene alkene propionyl resorcinol compounds and medical use WENZHOU MEDICAL COLLEGE (CN) 2009-07-29 CN disclosed
US-7553503-B2 Phyto-nutraceutical synergistic composition for Parkinson's Disease Olalde Rangel, Jose Angel (US) 2009-06-30 US disclosed
US-7553501-B2 Immune phyto-neutraceutical composition Olalde Rangel, Jose Angel (US) 2009-06-30 US disclosed
US-20090155377-A1 Synergistic Phytoceutical Compositions OLALDE RANGEL JOSE ANGEL 2009-06-18 US disclosed
CN-101457192-A Papaya sake and method for producing the same HENAN HUAIYUAN WINE CO LTD (CN) 2009-06-17 CN disclosed
EP-1804787-A4 FLAVONOID COMPOSITION FOR TREATING ORAL DISEASES UNIGEN PHARMACEUTICALS INC (US) 2009-01-14 EP disclosed
EP-2011517-A1 Polynucleotide binding complexes comprising sterols and saponin Nordic Vaccine Technology A/S (DK) 2009-01-07 EP disclosed
CN-101328123-A 5-oxo-substituted benzene acryloyl quinate methyl ester compound and use thereof UNIV ZHEJIANG (CN) 2008-12-24 CN disclosed
CN-101293833-A 5-oxygen-substituted benzene alkene propionyl quinic acid compounds and medicine uses thereof WENZHOU MEDICAL COLLEGE (CN) 2008-10-29 CN disclosed
CN-101293834-A 3,4-di-oxygen-[3-substituted alkene propionyl]quinic acid compounds and medicine uses thereof WENZHOU MEDICAL COLLEGE (CN) 2008-10-29 CN disclosed
EP-1377320-B1 POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS NORDIC VACCINE TECHNOLOGY AS (DK) 2008-10-01 EP disclosed
US-20080206162-A1 Composition and Methods for Treating Alzheimer's Disease and Other Amyloidoses UNIVERSITY OF WASHINGTON 2008-08-28 US disclosed
US-7416748-B2 Arthritis phyto-nutraceutical synergistic composition Olade Rangel, Jose Angel (US) 2008-08-26 US disclosed
CN-101212963-A Application of chlorogenic acid in preparing medicine for increasing bone marrow cell efficacy SICHUAN NYNESTEP BIOTECH CO LT (CN) 2008-07-02 CN disclosed
US-7390512-B2 Multiple sclerosis synergistic phyto-nutraceutical composition Olalde Rangel, Jose Angel (US) 2008-06-24 US disclosed
US-20080118583-A1 PHYTO-NUTRACEUTICAL SYNERGISTIC COMPOSITION FOR PARKINSON'S DISEASE OLALDE RANGEL JOSE ANGEL 2008-05-22 US disclosed
US-20080118582-A1 Synergistic Inmune Phyto-Nutraceutical Composition OLALDE RANGEL JOSE ANGEL 2008-05-22 US disclosed
US-20080089946-A1 Synergistic Phytoceutical Compositions OLALDE RANGEL JOSE A 2008-04-17 US disclosed
WO-2007115181-A9 COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF EASTMAN CHEM CO (US) 2008-04-03 WO disclosed
US-20080081046-A1 MULTIPLE SCLEROSIS SYNERGISTIC PHYTO-NUTRACEUTICAL COMPOSITION OLALDE JOSE ANGEL 2008-04-03 US disclosed
US-20080063658-A1 SYNERGISTIC HIV/AIDS AND/OR IMMUNE DISEASE PHYTO-NUTRACEUTICAL COMPOSITION OLALDE RANGEL JOSE ANGEL 2008-03-13 US disclosed
US-20080044496-A1 ARTHRITIS PHYTO-NUTRACEUTICAL SYNERGISTIC COMPOSITION OLALDE RANGEL JOSE ANGEL 2008-02-21 US disclosed
CN-101121662-A Chlorogenic acid ester derivative, preparation method and application thereof in pharmaceutical preparation SICHUAN NYNESTEP BIOTECH CO LT (CN) 2008-02-13 CN disclosed
WO-2008008837-A2 A METHOD OF INCREASING TRYPTOPHAN AND NICOTINAMIDE LEVELS IN VIVO LYNPETE TRADING 6 (PTY) LTD. TRADING AS GENETIC HEALTH ENTERPRISES (ZA) 2008-01-17 WO disclosed
US-20080003300-A1 Compostions containing Mg/Zn/F-CaP plus inhibitors of pro-inflammatory Cytokines (a combination of a Free-B-Ring flavonoids and a flavan) for osteoporosis prevention, therapy and treatment of bone diseases GAFFAR MARIA C 2008-01-03 US disclosed
US-7314642-B2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants PROTAMED, INC. 2008-01-01 US disclosed
US-7303772-B2 Synergistic phytoceutical compositions OLALDE RANGEL JOSE ANGEL 2007-12-04 US disclosed
US-20070254859-A1 Compounds exhibiting efflux inhibitor activity and composition and uses thereof EASTMAN CHEMICAL COMPANY 2007-11-01 US disclosed
US-20070248703-A1 Topical Phytotherapeutic Compound for the Treatment of Herpes Based on Uncaria Tomentosa and Extraction Process for Obtaining a Vegetal Extract from Uncaria Tomentosa HERBARIUM LABORATORIO BOTANICO LTDA. (BR) 2007-10-25 US disclosed
US-7285293-B2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants COGNITIVE CLARITY INC. 2007-10-23 US disclosed
WO-2007115181-A2 COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF EASTMAN CHEMICAL COMPANY (US) 2007-10-11 WO disclosed
CN-100341845-C Chlorogenic acid extracting and purifying process from sunflower seed dregs UNIV JIANGNAN (CN) 2007-10-10 CN disclosed
EP-1804787-A2 FLAVONOID COMPOSITION FOR TREATING ORAL DISEASES Unigen Pharmaceuticals, Inc. (US) 2007-07-11 EP disclosed
WO-2007059441-A2 SYNERGISTIC PHYTOCEUTICAL COMPOSITIONS OLALDE RANGEL JOSE ANGEL (US) 2007-05-24 WO disclosed
EP-1786446-A2 TOPICAL PHYTOTHERAPIC COMPOUND FOR THE TREATMENT OF HERPES BASED ON UNCARIA TOMENTOSA AND EXTRACTION PROCESS FOR OBTAINING A VEGETAL EXTRACT FROM UNCARIA TOMENTOSA HERBARIUM LABORATÓRIO BOTÁNICO LTDA. (BR) 2007-05-23 EP disclosed
US-20070104728-A1 Synergistic phytoceutical compositions OLALDE RANGEL JOSE A 2007-05-10 US disclosed
EP-1019044-B1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIV WASHINGTON (US) 2007-04-11 EP disclosed
EP-1489910-B1 A NEW ANTIVIRAL AGENT FROM INDIAN HORSE CHESTNUT AESCULUS INDICA COUNCIL SCIENT IND RES (IN) 2007-04-11 EP disclosed
WO-2006045056-A2 FLAVONOID COMPOSITION FOR TREATING ORAL DISEASES UNIGEN PHARMACEUTICALS, INC. (US) 2006-04-27 WO disclosed
US-7029710-B2 Methods of isolation of amyloid inhibitory ingredients within Uncaria tomentosa UNIVERSITY OF WASHINGTON (US) 2006-04-18 US disclosed
US-20060079467-A1 administering plants extracts which inhibits cyclooxygenases and lipoxygenases, and reduces cytokine production; periodontal diseases UNIGEN PHARMACEUTICALS, INC. (US) 2006-04-13 US disclosed
WO-2006024120-A2 TOPICAL PHYTOTHERAPEUTIC COMPOUND FOR THE TREATMENT OF HERPES BASED ON UNCARIA TOMENTOSA AND EXTRACTION PROCESS FOR OBTAINING A VEGETAL EXTRACT FROM UNCARIA TOMENTOSA HERBARIUM LABORATÓRIO BOTÂNICO LTDA. (BR) 2006-03-09 WO disclosed
CN-1740137-A Chlorogenic acid extracting and purifying process from sunflower seed dregs UNIV JIANGNAN (CN) 2006-03-01 CN disclosed
CN-1679795-A Anti-cancer extracts from thinleaf adina root and its making method and use HUANAN SCIENCE & ENGINEERING (CN) 2005-10-12 CN disclosed
CN-1679796-A Anti-cancer compound preparation of giant knotweed, Tengli root and thinleaf adina root and its making method and use HUANAN SCIENCE & ENGINEERING (CN) 2005-10-12 CN disclosed
US-6939570-B1 Composition and methods for treating Alzheimer's disease and other amyloidoses UNIVERSITY OF WASHINGTON (US) 2005-09-06 US disclosed
US-6929808-B2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants PROTEOTECH, INC. (US) 2005-08-16 US disclosed
EP-1489910-A1 A NEW ANTIVIRAL AGENT FROM INDIAN HORSE CHESTNUT AESCULUS INDICA Council of Scientific and Industrial Research (IN) 2004-12-29 EP disclosed
CN-1558722-A Feed and fertilizer containing pentacyclic triterpenes 日清奥利友株式会社 2004-12-29 CN disclosed
US-20040175447-A1 Feeds and fertilizers containing pentacyclic triterpenes THE NISSHIN OILLIO, LTD. (JP) 2004-09-09 US disclosed
EP-1335738-A4 METHODS OF ISOLATING AMYLOID-INHIBITING COMPOUNDS AND USE OF COMPOUNDS ISOLATED FROM UNCARIA TOMENTOSA AND RELATED PLANTS PROTEOTECH INC (US) 2004-09-08 EP disclosed
US-20040137092-A1 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein COGNITIVE CLARITY INC. 2004-07-15 US disclosed
EP-1430787-A1 FEEDS AND FERTILIZERS CONTAINING PENTACYCLIC TRITERPENES The Nisshin OilliO, Ltd. (JP) 2004-06-23 EP disclosed
US-20040086553-A1 Foods and beverages for whitening and orally administered whitening agents THE NISSHIN OILLIO, LTD. 2004-05-06 US disclosed
US-20040086585-A1 Composition and methods for treating Alzheimer's disease and other amyloidoses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-05-06 US disclosed
US-20040076698-A1 Composition and methods for treating Alzheimer's disease and other amyloidoses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-04-22 US disclosed
EP-1409009-A1 THERAPEUTICAL VACCINATION Nordic Vaccine Technology A/S (DK) 2004-04-21 EP disclosed
US-20040057964-A1 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants PROTAMED, INC. 2004-03-25 US disclosed
EP-1377320-A2 POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS Nordic Vaccine Technology A/S (DK) 2004-01-07 EP disclosed
EP-1019044-A4 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIV WASHINGTON (US) 2004-01-07 EP disclosed
WO-2003079795-A1 A NEW ANTIVIRAL AGENT FROM INDIAN HORSE CHESTNUT AESCULUS INDICA COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2003-10-02 WO disclosed
EP-1340501-A1 BEAUTIFYING FOODS AND DRINKS AND PERORAL BEAUTIFYING PREPARATIONS The Nisshin Oillio, Ltd. (JP) 2003-09-03 EP disclosed
EP-1335738-A2 METHODS OF ISOLATING AMYLOID-INHIBITING COMPOUNDS AND USE OF COMPOUNDS ISOLATED FROM UNCARIA TOMENTOSA AND RELATED PLANTS Proteotech, Inc. (US) 2003-08-20 EP disclosed
US-6607758-B2 Methods for inhibiting and reducing amyloid fibril formation associated with Alzheimer's Disease and other amyloidoses UNIVERSITY OF WASHINGTON 2003-08-19 US disclosed
US-20030086949-A1 Method for testing a substance which is potentially active in the field of lipolysis and its mainly cosmetic use COLETICA 2003-05-08 US disclosed
WO-2002102407-A1 THERAPEUTICAL VACCINATION NORDIC VACCINE TECHNOLOGY A/S (DK) 2002-12-27 WO disclosed
US-20020197692-A1 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants PROTAMED, INC. 2002-12-26 US disclosed
WO-2002080981-A2 POLYNUCLEOTIDE BINDING COMPLEXES COMPRISING STEROLS AND SAPONINS NORDIC VACCINE TECHNOLOGY A/S (DK) 2002-10-17 WO disclosed
WO-2002042429-A2 METHODS OF ISOLATING AMYLOID-INHIBITING COMPOUNDS AND USE OF COMPOUNDS ISOLATED FROM UNCARIA TOMENTOSA AND RELATED PLANTS PROTEOTECH, INC. (US) 2002-05-30 WO disclosed
US-6346280-B1 Composition and methods for inhibiting the formation of brain amyloid deposits UNIVERSITY OF WASHINGTON 2002-02-12 US disclosed
EP-0815868-B1 A CHINESE DRUG COMPOSITION FOR TREATMENT OF PEPTIC ULCER ZHANG YONGCHUAN (CN) 2002-02-06 EP disclosed
US-6344219-B1 OILS OF CHENOPODIUM AMBROSIODES AND ADINA PILULIFERA THAT INHIBIT PYLORIC SPIRILLUM ZHANG YONGCHUAN (CN) 2002-02-05 US disclosed
US-20010055630-A1 Compostion and methods for treating alzheimer's disease and other amyloidoses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2001-12-27 US disclosed
US-6264994-B1 Compositions for treating alzheimer's disease and other amyloidoses UNIVERSITY OF WASHINGTON 2001-07-24 US disclosed
EP-1019044-A1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES University of Washington (US) 2000-07-19 EP disclosed
WO-2000033659-A1 COMPOSITIONS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIVERSITY OF WASHINGTON (US) 2000-06-15 WO disclosed
WO-2000030666-A1 COMPOSITION AND METHODS FOR INHIBITING THE FORMATION OF BRAIN AMYLOID DEPOSITS UNIVERSITY OF WASHINGTON (US) 2000-06-02 WO disclosed
EP-0725051-B1 Copolyesters, molded articles from the same and aromatic triols used for producing the same KURARAY CO (JP) 1999-06-02 EP disclosed
WO-1998051302-A1 COMPOSITION AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND OTHER AMYLOIDOSES UNIVERSITY OF WASHINGTON (US) 1998-11-19 WO disclosed
EP-0815868-A1 A CHINESE DRUG COMPOSITION FOR TREATMENT OF PEPTIC ULCER AND PREPARATION THEREOF Zhang, Yongchuan (CN) 1998-01-07 EP disclosed
US-5648449-A Copolyesters, molded articles from the same and aromatic triols used for producing the same KURARAY CO., LTD. (JP) 1997-07-15 US disclosed
EP-0725051-A2 Copolyesters, molded articles from the same and aromatic triols used for producing the same KURARAY CO., LTD. (JP) 1996-08-07 EP disclosed
US-4606911-A PENTACYCLIC ACID TRITERPENES ROHTO PHARMACEUTICAL CO. LTD. (JP) 1986-08-19 US disclosed
US-4606911-A PENTACYCLIC ACID TRITERPENES ROHTO PHARMACEUTICAL CO. LTD. (JP) 1986-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254859-A1 Compounds exhibiting efflux inhibitor activity and composition and uses thereof ABCC4, NCOA4, NR4A3 PTPN1 630/4885SENP1 4396/4885POLB 3941/4885
US-20110020226-A1 PARTICLE STRUCTURES COMPRISING STEROLS AND SAPONINS LSS, SNRPE, HLA-C PTPN1 2398/4885SENP1 3710/4885POLB 93/4885
US-20100227827-A1 METHOD OF INCREASING TRYPTOPHAN AND NICOTINAMIDE LEVELS IN VIVO NNMT, AADAT, AANAT PTPN1 4034/4885SENP1 2330/4885POLB 1423/4885
US-20080003300-A1 Compostions containing Mg/Zn/F-CaP plus inhibitors of pro-inflammatory Cytokines (a combination of a Free-B-Ring flavonoids and a flavan) for osteoporosis prevention, therapy and treatment of bone diseases IL1B, TNF, SLC30A6 PTPN1 4344/4885SENP1 652/4885POLB 733/4885
US-20040175447-A1 Feeds and fertilizers containing pentacyclic triterpenes TYR, MC1R, MITF PTPN1 778/4885SENP1 3255/4885POLB 4180/4885
US-20180207113-A1 VIVO INTRACELLULAR REPROGRAMMING COMPOSITION AND METHOD OF MAKING AND USING SAME MTOR, SHMT2, DNMT3A PTPN1 4124/4885SENP1 1081/4885POLB 91/4885
US-20060079467-A1 administering plants extracts which inhibits cyclooxygenases and lipoxygenases, and reduces cytokine production; periodontal diseases LPO, GLA, LOX PTPN1 3182/4885SENP1 1501/4885POLB 297/4885
US-20250170038-A1 DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES MAS1, CYP51A1, EYA2 PTPN1 2665/4885SENP1 681/4885POLB 2096/4885
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME PIGS, TAS2R13, CEL PTPN1 3395/4885SENP1 2309/4885POLB 4105/4885
US-20040086553-A1 Foods and beverages for whitening and orally administered whitening agents NQO1, TYR, CYP2A13 PTPN1 2921/4885SENP1 1598/4885POLB 3164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.